EpiPen Maker Mylan Quietly Steers Effort to Protect Its Price

Inclusion on a federal list would mean Mylan could keep its list price high — or even raise it — without patients complaining. But consumers would feel it indirectly.

from NYT > Health http://ift.tt/2cNRote
via health&fitness